These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 22491032)

  • 1. Enhancers: emerging roles in cell fate specification.
    Ong CT; Corces VG
    EMBO Rep; 2012 Apr; 13(5):423-30. PubMed ID: 22491032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone ChIP-Seq identifies differential enhancer usage during chondrogenesis as critical for defining cell-type specificity.
    Cheung K; Barter MJ; Falk J; Proctor CJ; Reynard LN; Young DA
    FASEB J; 2020 Apr; 34(4):5317-5331. PubMed ID: 32058623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers.
    Sérandour AA; Avner S; Percevault F; Demay F; Bizot M; Lucchetti-Miganeh C; Barloy-Hubler F; Brown M; Lupien M; Métivier R; Salbert G; Eeckhoute J
    Genome Res; 2011 Apr; 21(4):555-65. PubMed ID: 21233399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chromatin signatures of enhancers and their dynamic regulation.
    Barral A; Déjardin J
    Nucleus; 2023 Dec; 14(1):2160551. PubMed ID: 36602897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique chromatin signature uncovers early developmental enhancers in humans.
    Rada-Iglesias A; Bajpai R; Swigut T; Brugmann SA; Flynn RA; Wysocka J
    Nature; 2011 Feb; 470(7333):279-83. PubMed ID: 21160473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants.
    Parker SC; Stitzel ML; Taylor DL; Orozco JM; Erdos MR; Akiyama JA; van Bueren KL; Chines PS; Narisu N; ; Black BL; Visel A; Pennacchio LA; Collins FS; ;
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17921-6. PubMed ID: 24127591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate Promoter and Enhancer Identification in 127 ENCODE and Roadmap Epigenomics Cell Types and Tissues by GenoSTAN.
    Zacher B; Michel M; Schwalb B; Cramer P; Tresch A; Gagneur J
    PLoS One; 2017; 12(1):e0169249. PubMed ID: 28056037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer RNA: biogenesis, function, and regulation.
    Ye R; Cao C; Xue Y
    Essays Biochem; 2020 Dec; 64(6):883-894. PubMed ID: 33034351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin signatures of active enhancers.
    Spicuglia S; Vanhille L
    Nucleus; 2012 Mar; 3(2):126-31. PubMed ID: 22555596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bidirectional transcription initiation marks accessible chromatin and is not specific to enhancers.
    Young RS; Kumar Y; Bickmore WA; Taylor MS
    Genome Biol; 2017 Dec; 18(1):242. PubMed ID: 29284524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H3K27ac separates active from poised enhancers and predicts developmental state.
    Creyghton MP; Cheng AW; Welstead GG; Kooistra T; Carey BW; Steine EJ; Hanna J; Lodato MA; Frampton GM; Sharp PA; Boyer LA; Young RA; Jaenisch R
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21931-6. PubMed ID: 21106759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of chromatin dynamics in immune cell development.
    Winter DR; Amit I
    Immunol Rev; 2014 Sep; 261(1):9-22. PubMed ID: 25123274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eukaryotic enhancers: common features, regulation, and participation in diseases.
    Erokhin M; Vassetzky Y; Georgiev P; Chetverina D
    Cell Mol Life Sci; 2015 Jun; 72(12):2361-75. PubMed ID: 25715743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of enhancer chromatin: what, how, and why?
    Calo E; Wysocka J
    Mol Cell; 2013 Mar; 49(5):825-37. PubMed ID: 23473601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early enhancer establishment and regulatory locus complexity shape transcriptional programs in hematopoietic differentiation.
    González AJ; Setty M; Leslie CS
    Nat Genet; 2015 Nov; 47(11):1249-59. PubMed ID: 26390058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics of Muscle- and Brain-Specific Expression of KLHL Family Genes.
    Ehrlich KC; Baribault C; Ehrlich M
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33182325
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancer function: new insights into the regulation of tissue-specific gene expression.
    Ong CT; Corces VG
    Nat Rev Genet; 2011 Apr; 12(4):283-93. PubMed ID: 21358745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Enhancing' red cell fate through epigenetic mechanisms.
    Rossmann MP; Zon LI
    Curr Opin Hematol; 2021 May; 28(3):129-137. PubMed ID: 33741760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation patterns expose variations in enhancer-chromatin modifications during embryonic stem cell differentiation.
    Alajem A; Roth H; Ratgauzer S; Bavli D; Motzik A; Lahav S; Peled I; Ram O
    PLoS Genet; 2021 Apr; 17(4):e1009498. PubMed ID: 33844685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.